Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Morning Coffee on JPMorgan Chase (JPM): Look, Ma. I'm Net Long an Additional $3.6M Worth of Paper
-
Canaccord Genuity Morning Coffee on Halliburton (HAL): Counting the Beans
-
Canaccord Genuity Software Earnings Preview: Who Could Be Up, Down, or Stagnant
-
Notable Analyst Rating Changes 07/24: (PCS) (GT) (TLM) Upgraded; (TSO) (DV) (RSH) Downgraded
-
Canaccord Genuity Morning Coffee on Coca-Cola Enterprises (CCE): Leaves You Thirsty for More
-
Canaccord Genuity Morning Coffee on Dogs of the Dow: I'm Large and In Charge
-
Canaccord Genuity Downgrades InterMune Inc. (ITMN) to Hold; Closer Look at Esbriet EU Launch
-
Canaccord Genuity Maintains a 'Hold' on Rubicon Technology (RBCN); SoS: No Mayday, but Not Enough for Upgrade
-
Canaccord Genuity Maintains a 'Hold' on Texas Instruments (TXN); Seasonal Growth Fails to Materialize
-
Canaccord Genuity Starts Avago Technologies (AVGO) at Buy; Strong IP; Management Executing
-
Canaccord Genuity Upgrades Talisman Energy (TLM) to Buy; NXY/CNOOC Deal Offers Positive Read Through
-
Canaccord Genuity Upgrades Talisman Energy (TLM) to Buy
-
Canaccord Genuity Starts Avago Technologies (AVGO) at Buy
-
Canaccord Genuity Downgrades InterMune Inc. (ITMN) to Hold
-
Canaccord Genuity Downgrades Nexen Inc. (NXY) to Sell
-
Notable Analyst Rating Changes 07/23: (MDC) (ONXX) (BYD) Upgraded; (MAR) (VRSN) (WAG) Downgraded
-
Canaccord Genuity Starts Exa Corporation (EXA) at Buy
-
Canaccord Genuity Downgrades AMD (AMD) to Hold
-
Anthera (ANTH) Prices 33M Offering at $1/Share
-
Notable Analyst Rating Changes 07/18: (TIF) (ERF) (KMT) Upgraded; (SKS) (CAT) (EDU) Downgraded
-
Canaccord Genuity Downgrades AuRico Gold (AUQ) to Hold
-
Notable Analyst Rating Changes 07/17: (DIS) (ARO) CLR) Upgraded; (ACI) (NOK) (DE) Downgraded
-
Canaccord Genuity Upgrades Continental Resources (CLR) to Buy
-
Globus Medical (GMED) Sees IPO Price of $16-$18/Share
-
Canaccord Genuity Morning Coffee on Marriott International (MAR): Their Natural Enemy? The Winnebago
-
Canaccord Genuity Morning Coffee on Infosys (INFY): The Times, They are a-Changin'
-
Shares of 3D Systems (DDD) Continue on a Tear, Adding to 115% Gain Year-To-Date
-
Canaccord Genuity Maintains a 'Hold' on AngioDynamics (ANGO); Bumping Estimates After Q4 Results
-
Natural Grocers (NGVC) Sees IPO Price of $13 - $15/Share
-
Canaccord Genuity Reiterates a 'Buy' on Quidel Corp. (QDEL); Q2 Preview: Exciting Launch in Series of New Products
-
Canaccord Genuity Q2 Preview on Quest Diagnostics (NYSE: DGX): Sidelined Until More Confident in New CEO's Ability
-
Canaccord Genuity Maintains a 'Buy' on OraSure Technologies (OSUR); Q2 Preview: Build on its Momentum
-
Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles
-
Canaccord Genuity Maintains a 'Buy' on Laboratory Corporation (LH); Q2 Preview: Successful Commercial Lab Business
-
Canaccord Genuity Maintains a 'Hold' on Genomic Health (GHDX); Q2 Preview: Is Strong Growth Attainable?
-
Canaccord Genuity Maintains a 'Buy' on GenMark Diagnostics (GNMK); Q2 Preview: Expecting Really Good Numbers
-
Canaccord Genuity maintains a 'Buy' on Exact Sciences (EXAS); Q2 Preview: Unique Opportunity Presented
-
Canaccord Genuity Maintains a 'Buy' on Cepheid (CPHD); Q2 Preview: Consumable Growth is Key
-
Canaccord Genuity Maintains a 'Hold' on Becton Dickinson (BDX); Q3 Preview: Looking For Signs of Stabilization
-
Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Q2 Preview: Trials For AppyScore Start Soon
-
Canaccord Genuity Maintains a 'Buy' on Alere (ALR); Q2 Preview: Looking for Clarity
-
Canaccord Genuity Q1 Preview on Abaxis Inc. (ABAX): Too Far, Too Fast
-
Canaccord Genuity on Amazon.com (AMZN): Achievement Unlocked
-
Canaccord Genuity Maintains a 'Hold' on Badger Meter (BMI); Remain Comfortable with Q2 Estimates
-
Canaccord Genuity Maintains a 'Buy' on Xylem (XYL); Cutting Price Target Ahead of Quarterly Results
-
Canaccord Genuity Maintains a 'Hold' on Pentair (PNR); June Quarter Preview
-
Canaccord Genuity Suggests Buying Hologic (HOLX) on Weakness After Mixed Q3 Pre-Announcement
-
Canaccord Genuity Assumes Coverage on Optimer Pharmaceuticals (OPTR) at Buy; Near Term Growth Driven by Unmet Need
-
Canaccord Genuity Maintains a 'Buy' on NVIDIA (NVDA); Upstream Checks Still Positive Despite Weak PCs
-
Canaccord Genuity Reiterates a 'Buy' on Rosetta Resources (ROSE); NGL Weakness Priced In; Greater Oil Emphasis Isn't

